[(2R,3R,4S,5R,6R)-3,4,5-triacetyloxy-6-[(5Z)-5-[[3-(4-bromophenyl)-1-phenylpyrazol-4-yl]methylidene]-2-oxo-4-sulfanylidene-1,3-thiazolidin-3-yl]oxan-2-yl]methyl acetate

C33H30BrN3O10S2 — CID 46861658

IUPAC[(2R,3R,4S,5R,6R)-3,4,5-triacetyloxy-6-[(5Z)-5-[[3-(4-bromophenyl)-1-phenylpyrazol-4-yl]methylidene]-2-oxo-4-sulfanylidene-1,3-thiazolidin-3-yl]oxan-2-yl]methyl acetate
SMILESCC(=O)OC[C@H]1O[C@@H](N2C(=O)S/C(=C\c3cn(-c4ccccc4)nc3-c3ccc(Br)cc3)C2=S)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O
InChIInChI=1S/C33H30BrN3O10S2/c1-17(38)43-16-25-28(44-18(2)39)29(45-19(3)40)30(46-20(4)41)31(47-25)37-32(48)26(49-33(37)42)14-22-15-36(24-8-6-5-7-9-24)35-27(22)21-10-12-23(34)13-11-21/h5-15,25,28-31H,16H2,1-4H3/b26-14-/t25-,28-,29+,30-,31-/m1/s1
InChIKeyBKGXBXPBYDEOQZ-VCKOCONSSA-N
MW772.65 g/mol
LogP5.22
Rot. Bonds9

About [(2R,3R,4S,5R,6R)-3,4,5-triacetyloxy-6-[(5Z)-5-[[3-(4-bromophenyl)-1-phenylpyrazol-4-yl]methylidene]-2-oxo-4-sulfanylidene-1,3-thiazolidin-3-yl]oxan-2-yl]methyl acetate

[(2R,3R,4S,5R,6R)-3,4,5-triacetyloxy-6-[(5Z)-5-[[3-(4-bromophenyl)-1-phenylpyrazol-4-yl]methylidene]-2-oxo-4-sulfanylidene-1,3-thiazolidin-3-yl]oxan-2-yl]methyl acetate (PubChem CID 46861658) has the molecular formula C33H30BrN3O10S2 and a molecular weight of 772.65 g/mol. Its IUPAC name is [(2R,3R,4S,5R,6R)-3,4,5-triacetyloxy-6-[(5Z)-5-[[3-(4-bromophenyl)-1-phenylpyrazol-4-yl]methylidene]-2-oxo-4-sulfanylidene-1,3-thiazolidin-3-yl]oxan-2-yl]methyl acetate.

Molecular Properties

Compound Name[(2R,3R,4S,5R,6R)-3,4,5-triacetyloxy-6-[(5Z)-5-[[3-(4-bromophenyl)-1-phenylpyrazol-4-yl]methylidene]-2-oxo-4-sulfanylidene-1,3-thiazolidin-3-yl]oxan-2-yl]methyl acetate
PubChem CID46861658
Molecular FormulaC33H30BrN3O10S2
Molecular Weight772.65 g/mol
Exact Mass771.06
IUPAC Name[(2R,3R,4S,5R,6R)-3,4,5-triacetyloxy-6-[(5Z)-5-[[3-(4-bromophenyl)-1-phenylpyrazol-4-yl]methylidene]-2-oxo-4-sulfanylidene-1,3-thiazolidin-3-yl]oxan-2-yl]methyl acetate
SMILESCC(=O)OC[C@H]1O[C@@H](N2C(=O)S/C(=C\c3cn(-c4ccccc4)nc3-c3ccc(Br)cc3)C2=S)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O
InChIInChI=1S/C33H30BrN3O10S2/c1-17(38)43-16-25-28(44-18(2)39)29(45-19(3)40)30(46-20(4)41)31(47-25)37-32(48)26(49-33(37)42)14-22-15-36(24-8-6-5-7-9-24)35-27(22)21-10-12-23(34)13-11-21/h5-15,25,28-31H,16H2,1-4H3/b26-14-/t25-,28-,29+,30-,31-/m1/s1
InChIKeyBKGXBXPBYDEOQZ-VCKOCONSSA-N
XLogP5.22
TPSA152.56 Ų
H-Bond Donors
H-Bond Acceptors14
Rotatable Bonds9
Heavy Atoms49
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500772.65
LogP ≤ 55.22
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1014

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'ene_rhod_E(8)', 'substructure': 'N/A'}, {'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}, {'alert_name': 'Thiocarbonyl_group', 'substructure': 'N/A'}, {'alert_name': 'thioester', 'substructure': 'N/A'}

Analyze [(2R,3R,4S,5R,6R)-3,4,5-triacetyloxy-6-[(5Z)-5-[[3-(4-bromophenyl)-1-phenylpyrazol-4-yl]methylidene]-2-oxo-4-sulfanylidene-1,3-thiazolidin-3-yl]oxan-2-yl]methyl acetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(2R,3R,4S,5R,6R)-3,4,5-triacetyloxy-6-[(5Z)-5-[[3-(4-bromophenyl)-1-phenylpyrazol-4-yl]methylidene]-2-oxo-4-sulfanylidene-1,3-thiazolidin-3-yl]oxan-2-yl]methyl acetate?
The IUPAC name of [(2R,3R,4S,5R,6R)-3,4,5-triacetyloxy-6-[(5Z)-5-[[3-(4-bromophenyl)-1-phenylpyrazol-4-yl]methylidene]-2-oxo-4-sulfanylidene-1,3-thiazolidin-3-yl]oxan-2-yl]methyl acetate (CID 46861658) is [(2R,3R,4S,5R,6R)-3,4,5-triacetyloxy-6-[(5Z)-5-[[3-(4-bromophenyl)-1-phenylpyrazol-4-yl]methylidene]-2-oxo-4-sulfanylidene-1,3-thiazolidin-3-yl]oxan-2-yl]methyl acetate.
What is the SMILES notation for [(2R,3R,4S,5R,6R)-3,4,5-triacetyloxy-6-[(5Z)-5-[[3-(4-bromophenyl)-1-phenylpyrazol-4-yl]methylidene]-2-oxo-4-sulfanylidene-1,3-thiazolidin-3-yl]oxan-2-yl]methyl acetate?
The canonical SMILES for [(2R,3R,4S,5R,6R)-3,4,5-triacetyloxy-6-[(5Z)-5-[[3-(4-bromophenyl)-1-phenylpyrazol-4-yl]methylidene]-2-oxo-4-sulfanylidene-1,3-thiazolidin-3-yl]oxan-2-yl]methyl acetate is CC(=O)OC[C@H]1O[C@@H](N2C(=O)S/C(=C\c3cn(-c4ccccc4)nc3-c3ccc(Br)cc3)C2=S)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O.
What is the InChIKey of [(2R,3R,4S,5R,6R)-3,4,5-triacetyloxy-6-[(5Z)-5-[[3-(4-bromophenyl)-1-phenylpyrazol-4-yl]methylidene]-2-oxo-4-sulfanylidene-1,3-thiazolidin-3-yl]oxan-2-yl]methyl acetate?
The InChIKey is BKGXBXPBYDEOQZ-VCKOCONSSA-N. The full InChI is InChI=1S/C33H30BrN3O10S2/c1-17(38)43-16-25-28(44-18(2)39)29(45-19(3)40)30(46-20(4)41)31(47-25)37-32(48)26(49-33(37)42)14-22-15-36(24-8-6-5-7-9-24)35-27(22)21-10-12-23(34)13-11-21/h5-15,25,28-31H,16H2,1-4H3/b26-14-/t25-,28-,29+,30-,31-/m1/s1.
What are the key properties of [(2R,3R,4S,5R,6R)-3,4,5-triacetyloxy-6-[(5Z)-5-[[3-(4-bromophenyl)-1-phenylpyrazol-4-yl]methylidene]-2-oxo-4-sulfanylidene-1,3-thiazolidin-3-yl]oxan-2-yl]methyl acetate?
[(2R,3R,4S,5R,6R)-3,4,5-triacetyloxy-6-[(5Z)-5-[[3-(4-bromophenyl)-1-phenylpyrazol-4-yl]methylidene]-2-oxo-4-sulfanylidene-1,3-thiazolidin-3-yl]oxan-2-yl]methyl acetate has a molecular weight of 772.65 g/mol, XLogP of 5.22, 9 rotatable bonds, 0 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for [(2R,3R,4S,5R,6R)-3,4,5-triacetyloxy-6-[(5Z)-5-[[3-(4-bromophenyl)-1-phenylpyrazol-4-yl]methylidene]-2-oxo-4-sulfanylidene-1,3-thiazolidin-3-yl]oxan-2-yl]methyl acetate is sourced from PubChem (CID 46861658), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).